parthenolide has been researched along with Cancer of the Thyroid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, M; Huang, LT; Wang, JH; Wang, Z | 1 |
| Huang, LT; Li, ML; Li, TJ; Luo, HY; Wang, JH; Wang, YB | 1 |
| Wang, J; Wang, Z; Yuan, L; Zhang, D | 1 |
3 other study(ies) available for parthenolide and Cancer of the Thyroid
| Article | Year |
|---|---|
Parthenolide leads to proteomic differences in thyroid cancer cells and promotes apoptosis.
Topics: Apoptosis; Humans; Proteomics; Sesquiterpenes; Thyroid Neoplasms | 2022 |
Untargeted lipidomic analysis and network pharmacology for parthenolide treated papillary thyroid carcinoma cells.
Topics: Humans; Lipidomics; Molecular Docking Simulation; Network Pharmacology; Reproducibility of Results; Thyroid Cancer, Papillary; Thyroid Neoplasms | 2023 |
Metabonomic study of the intervention effects of Parthenolide on anti-thyroid cancer activity.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Humans; Metabolome; Metabolomics; Reactive Oxygen Species; Sesquiterpenes; Thyroid Neoplasms | 2020 |